Risperdal – J&J Ignored the Dangers, Put Profits First

  • HOME
  • |
  • News & Updates

Risperdal – J&J Ignored the Dangers, Put Profits First

Yesterday Op-Ed Columnist for the New York Times, Nicholas Kristof, wrote an incriminating article about how the world’s fifth-largest pharmaceutical company, Johnson & Johnson went to market with the drug Risperdal.

“Risperdal is a cautionary tale: When we allow businesses to profit from crimes, we all lose.”-Nicholas Kristof

According to the article, J&J put profit above everything else when they marketed the drug. In fact, Kristof reports that J&J aggressively marketed the drug to the elderly even after Risperdal didn’t receive FDA approval for this population.

J&J then targeted children ignoring the fact that 5.5 percent of boys developed large breasts, a condition known as Gynecomastia, while taking Risperdal.

Read, Kristof’s entire piece here.

If you or a loved one have used Risperdal and suffered from Gynecomastia, you may have legal recourse to collect compensation for your damages. The experienced lawyers at Meshbesher & Spence will help you seek compensation for your injuries. Please fill out our case evaluation form or call 1-888-728-9866 to speak to an attorney. There is no cost or obligation to have your claim reviewed.

Related Information:

Risperdal Litigation

Risperdal: More Foster Children than Ever Taking this Drug

Risperdal: Gynecomastia and Lawsuits
BACK TO NEWS & UPDATES